TipRanks
Go Ultimate55% OFF

OWC Pharmaceutical Research (0OW) Financial Statements

OWC Pharmaceutical Research Financial Overview

OWC Pharmaceutical Research's market cap is currently $445. The company's EPS TTM is $-0.00; its P/E ratio is 0.00; OWC Pharmaceutical Research has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 18Dec 17
Income Statement
Total Revenue$ 0.00$ 0.00
Gross Profit――
Operating Income$ -4.30M$ -4.55M
EBITDA$ -3.56M$ -4.55M
Net Income$ -10.26M$ -4.56M
Balance Sheet
Cash & Short-Term Investments$ 3.46M$ 970.54K
Total Assets$ 3.55M$ 1.06M
Total Debt$ 0.00$ 0.00
Net Debt$ -3.46M$ -970.54K
Total Liabilities$ 12.99M$ 270.49K
Stockholders' Equity$ -9.44M$ 790.60K
Cash Flow
Free Cash Flow$ -2.53M$ -1.20M
Operating Cash Flow$ -2.50M$ -1.19M
Investing Cash Flow$ -28.00K$ -9.51K
Financing Cash Flow$ 5.02M$ 1.69M

Currency in USD

OWC Pharmaceutical Research Earnings and Revenue History

-12M-8M-4M00 %0.4 %0.8 %1.2 %EarningsProfit Margin20172018RevenueEarningsProfit Margin

OWC Pharmaceutical Research Debt to Assets

05M10M15M0 %150 %300 %450 %LiabilitiesDebt to Assets20172018AssetsLiabilitiesDebt to Assets

OWC Pharmaceutical Research Cash Flow

-4M-2M02M4M6M20172018OperatingInvestingFinancing

OWC Pharmaceutical Research Forecast EPS vs Actual EPS

0Q1 18EPS EstimateBeatMiss